United Therapeutics Announced World’s First Successful UKidney Transplant
On Dec. 17, 2024, United Therapeutics, a public benefit corporation, announced the world’s first transplant of a UKidney,…
Johns Hopkins and Family of Henrietta Lacks Break Ground on Building Named in Honor of Henrietta Lacks
On Oct. 28, 2024, the Johns Hopkins University and Johns Hopkins Medicine, together with descendants of Henrietta Lacks,…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
Biotechnology | CDC | Diagnostics | Genomics | Infectious Disease | Life Science News | Therapeutics
Maryland Department of Health issued consumer advisory for Boar’s Head liverwurst and other deli meat products due to possible Listeria contamination
On Jul. 26, 2024, the Maryland Department of Health advised consumers not to eat certain deli meats produced…
Maryland Department of Health announced positive case of locally acquired malaria
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
Trial of potential universal flu vaccine opened at NIH Clinical Center
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
USDA confirmed highly pathogenic Avian influenza in fock of commercial layer chickens in Maryland
On Mar. 5, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the presence…
First successful transplant of porcine heart into adult human with end-stage heart disease
On Jan. 10, 2022, in a first-of-its-kind surgery, a 57-year-old patient with terminal heart disease received a successful…
Development of WRAI’s pan-coronavirus vaccine showed promise
On Dec. 28, 2021, researchers at the Walter Reed Army Institute of Research in Silver Spring, Maryland announced…
Imported Monkeypox case reported in Maryland
On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…
Long-term study of children with COVID-19 began
On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, a first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle…
COVID-19 vaccine responses studied in people with immune deficits
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
Positive topline data showed Fostamatinib met primary endpoint of safety in phase 2 clinical trial in hospitalized COVID-19 patients
On Apr. 13, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
Rigel announced completion of patient enrollment for phase 2 trial of fostamatinib in hospitalized COVID-19 patients
On Mar. 11, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
Patriot Express Travel at BWI, SEATAC required on-site, rapid COVID-19 testing
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
Novavax announced facility expansion to support global vaccine development
On Oct. 30, 2020, Novavax announced the expansion of its Maryland campus to accommodate the companyï¾’s rapid growth…
Catalent signed agreement with AstraZeneca to expand manufacturing support for COVID-19 vaccine AZD1222
On Aug. 24, 2020, Catalent announced that it had contracted to provide drug substance manufacturing to AstraZeneca for…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
Altimmune announced manufacturing agreement with Vigene Biosciences for AdCOVIDï¾™ single dose intranasal vaccine candidate for COVID-19
On Jul. 22, 2020, Altimmune announced an agreement with Vigene Biosciences to manufacture AdCOVIDTM, Altimmuneï¾’s single-dose intranasal vaccine…
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
NIH began study to quantify undetected cases of coronavirus infection
On Apr. 10, 2020, a new study has begun recruiting at the NIH in Bethesda, Maryland, to determine…
The FDA announced publication of ARGOS SARS-CoV-2 reference grade sequence data
On Apr. 2, 2020, the FDAï¾—in collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository…
PharmAthene and Altimmune announced merger to create immunotherapeutics company targeting infectious diseases
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neural Systems Institute at The Rockefeller University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neural Systems…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
The Kavli Foundation awarded $20 million to establish the Kavli Neuroscience Discovery Institute at The Johns Hopkins University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
Trubion Pharmaceutical was acquired by Emergent BioSolutions
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…